 Michael Roshon
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Knowledge | 1 | 2007 | 51 | 0.270 |
Why?
| | Diffusion of Innovation | 1 | 2007 | 97 | 0.270 |
Why?
| | Embryonic Development | 2 | 2005 | 114 | 0.260 |
Why?
| | Clinical Protocols | 1 | 2007 | 255 | 0.250 |
Why?
| | Embryo Loss | 1 | 2005 | 4 | 0.240 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2005 | 7 | 0.240 |
Why?
| | Endometrium | 1 | 2004 | 61 | 0.220 |
Why?
| | Menstrual Cycle | 1 | 2004 | 121 | 0.210 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2003 | 7 | 0.210 |
Why?
| | Neomycin | 1 | 2003 | 7 | 0.210 |
Why?
| | Drug Resistance, Microbial | 1 | 2003 | 69 | 0.200 |
Why?
| | Mitochondria, Heart | 1 | 2003 | 94 | 0.200 |
Why?
| | 3' Untranslated Regions | 1 | 2003 | 138 | 0.190 |
Why?
| | Mutagenesis | 1 | 2003 | 181 | 0.190 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 149 | 0.190 |
Why?
| | Cloning, Molecular | 1 | 2003 | 524 | 0.190 |
Why?
| | Receptors, Estrogen | 1 | 2004 | 426 | 0.180 |
Why?
| | Sepsis | 1 | 2007 | 574 | 0.180 |
Why?
| | Shock, Septic | 1 | 2003 | 209 | 0.180 |
Why?
| | Mitochondrial Proteins | 1 | 2003 | 248 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2005 | 821 | 0.180 |
Why?
| | Oxygen Consumption | 1 | 2003 | 672 | 0.170 |
Why?
| | Pyrazines | 1 | 2020 | 86 | 0.160 |
Why?
| | Benzamides | 1 | 2020 | 207 | 0.160 |
Why?
| | Heart | 1 | 2003 | 637 | 0.160 |
Why?
| | Genetic Variation | 1 | 2004 | 937 | 0.160 |
Why?
| | Gene Expression | 1 | 2004 | 1472 | 0.160 |
Why?
| | Myocardium | 1 | 2003 | 980 | 0.140 |
Why?
| | RNA, Messenger | 2 | 2004 | 2708 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 249 | 0.140 |
Why?
| | Base Sequence | 4 | 2005 | 2142 | 0.130 |
Why?
| | Gene Expression Regulation | 2 | 2003 | 2548 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 341 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 335 | 0.120 |
Why?
| | RNA Splice Sites | 2 | 2004 | 44 | 0.110 |
Why?
| | Introns | 2 | 2005 | 251 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 958 | 0.100 |
Why?
| | Molecular Sequence Data | 4 | 2005 | 2832 | 0.100 |
Why?
| | Amino Acid Sequence | 3 | 2005 | 2058 | 0.090 |
Why?
| | Proviruses | 3 | 2004 | 12 | 0.080 |
Why?
| | Critical Illness | 2 | 2020 | 758 | 0.070 |
Why?
| | Genetic Vectors | 2 | 2005 | 312 | 0.070 |
Why?
| | Exons | 2 | 2004 | 342 | 0.060 |
Why?
| | Resuscitation | 1 | 2007 | 237 | 0.060 |
Why?
| | Retroviridae | 1 | 2005 | 99 | 0.060 |
Why?
| | RNA Splicing | 2 | 2004 | 262 | 0.060 |
Why?
| | Blotting, Southern | 1 | 2004 | 69 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2004 | 65 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 330 | 0.050 |
Why?
| | Uncoupling Protein 2 | 1 | 2003 | 8 | 0.050 |
Why?
| | Cecum | 1 | 2003 | 32 | 0.050 |
Why?
| | DNA Probes | 1 | 2003 | 61 | 0.050 |
Why?
| | Estrogen Receptor alpha | 1 | 2004 | 133 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 270 | 0.050 |
Why?
| | Hospital Mortality | 1 | 2007 | 850 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2003 | 138 | 0.050 |
Why?
| | Peroxidase | 1 | 2003 | 174 | 0.050 |
Why?
| | Virus Integration | 1 | 2003 | 69 | 0.050 |
Why?
| | Ion Channels | 1 | 2003 | 133 | 0.050 |
Why?
| | Quality of Health Care | 1 | 2007 | 608 | 0.050 |
Why?
| | Polyadenylation | 1 | 2003 | 40 | 0.050 |
Why?
| | Cell Line | 2 | 2005 | 2781 | 0.050 |
Why?
| | Alternative Splicing | 1 | 2004 | 218 | 0.050 |
Why?
| | Perfusion | 1 | 2003 | 197 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2004 | 429 | 0.050 |
Why?
| | Tumor Cells, Cultured | 1 | 2003 | 940 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 94 | 0.040 |
Why?
| | Acute Disease | 1 | 2003 | 980 | 0.040 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2000 | 28 | 0.040 |
Why?
| | Survival Analysis | 1 | 2003 | 1274 | 0.040 |
Why?
| | Animals | 5 | 2005 | 35361 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2003 | 380 | 0.040 |
Why?
| | Mice | 3 | 2005 | 16937 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2406 | 0.040 |
Why?
| | Monocytes | 1 | 2020 | 551 | 0.030 |
Why?
| | Mutation | 2 | 2005 | 3717 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2020 | 720 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2020 | 613 | 0.030 |
Why?
| | Liver | 1 | 2003 | 1839 | 0.030 |
Why?
| | Rats | 1 | 2003 | 5500 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2003 | 1614 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2003 | 4063 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1488 | 0.020 |
Why?
| | Humans | 4 | 2020 | 129650 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4897 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2736 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7086 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7133 | 0.020 |
Why?
| | Female | 3 | 2020 | 68776 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10230 | 0.020 |
Why?
| | Male | 2 | 2020 | 63681 | 0.010 |
Why?
| | Kanamycin Kinase | 1 | 2004 | 4 | 0.010 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2004 | 3 | 0.010 |
Why?
| | Terminal Repeat Sequences | 1 | 2004 | 15 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2004 | 361 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 406 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 643 | 0.010 |
Why?
| | Aged | 1 | 2020 | 22103 | 0.010 |
Why?
| | Genes, Lethal | 1 | 2000 | 29 | 0.010 |
Why?
| | Blastocyst | 1 | 2000 | 47 | 0.010 |
Why?
| | Fetal Death | 1 | 2000 | 56 | 0.010 |
Why?
| | Genes, Recessive | 1 | 2000 | 76 | 0.010 |
Why?
| | Homozygote | 1 | 2000 | 193 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2000 | 298 | 0.010 |
Why?
| | Methylation | 1 | 2000 | 230 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2000 | 504 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 31154 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1086 | 0.010 |
Why?
| | Stem Cells | 1 | 2000 | 577 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2000 | 5440 | 0.010 |
Why?
| | Pregnancy | 1 | 2000 | 6402 | 0.000 |
Why?
|
|
Roshon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|